Chinese mobile healthcare service Quyi announced that it has secured $40 million USD in Series B funding led by Baidu with participation of existing investors of HighLight Capital and SB China Capital. The company received a $8.5 million USD A round was received in September last year.

Founded in May 2015, Quyi is the developer of medical apps designed to shake up China’s medical sector. The Shanghai-based startup has developed three services that target at the core links in the industry.

Its flagship product Quyiyuan aims to improve the patient’s clinical experience by providing all kinds of related services from scheduling appointments, checking diagnosis reports, to making payments.

Quyi Hospital is a telemedicine system bringing together doctors to patients on mobile or in far-flung areas. The company is planning to roll out a new product to connect medical institutions and medical instrument manufacturers.

All of Qiyi’s apps are constructed on the company’s comprehensive information platform, which is supported by patient data collected from Quyiyuan and has deep integration with the systems of partner hospitals. The company claims to have more than 1000 public hospitals on board and expects the number to reach 2000 by the end of this year.

This tie-up will enable Quyi to gain more technical support from the Chinese internet giants in terms of big data, web security and cloud technology. Baidu has entered mobile heath industry with healthcare program “Beijing Health Cloud” and mobile app Baidu Doctor.

Related Articles:

Tencent Invests $40M USD In Medlinker To Help Doctors Communicate

Tencent Leads US$100M Investment in Chinese Medical Service Guahao[Updated]

Chinese Medtech Trends to Watch in 2015

Image credit: ShutterStock

Avatar photo

Emma Lee

Emma Lee (Li Xin) was TechNode's e-commerce and new retail reporter until June 2022, when she moved to Sixth Tone to cover technology and consumption. Get in touch with her via or Twitter.

Leave a comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.